
Laura Naysmith summarises a study of menopausal hormone therapy (also known as HRT), which suggests the treatment is linked with reduce the risk of psychosis relapse in menopausal women.
[read the full story...]Laura Naysmith summarises a study of menopausal hormone therapy (also known as HRT), which suggests the treatment is linked with reduce the risk of psychosis relapse in menopausal women.
[read the full story...]Michael Kalfas and Paul Leeks summarise a recent Danish study that assesses the risk of antidepressant-induced mania in patients with bipolar depression.
[read the full story...]Holly Fraser discusses new findings on whether and how we can predict antidepressant response using artificial intelligence.
[read the full story...]Kam Bhui reviews a conceptual framework developed to understand structural racism and suicide prevention for ethnoracially minoritised youth in the United States.
[read the full story...]Vishal Bhavsar reviews a recent study examining correlates of future violent behaviour in people being treated for schizophrenia in US-based treatment centres.
[read the full story...]Emmeline Lagunes Cordoba and Derek Tracy explore a case control study that looks at cognitive change in people with schizophrenia and other psychoses in the decade following the first episode.
[read the full story...]Keir Harding prepares for the #BIGSPD19 conference by reading Mike Crawford et al’s recent RCT on the clinical effectiveness and cost-effectiveness of lamotrigine in borderline personality disorder.
[read the full story...]Dafni Katsampa explores a recent prospective cohort study that investigates the association between smoking behaviour and cognitive functioning in patients with psychosis, their siblings and healthy control subjects.
[read the full story...]Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.
[read the full story...]Donncha Mullin summarises a recent meta-analysis of prospective cohort studies, which establishes a strong link between exercise and depression.
[read the full story...]